Juniper Pharmaceuticals Affirms Development Pathway for Oxybutynin Intra-vaginal Ring for Overactive Bladder in Women

JNP-0101 on Track for 2016 Investigational New Drug ("IND") Filing BOSTON, March 21, 2016 -- (Healthcare Sales & Marketing Network) -- Juniper Pharmaceuticals, Inc. (JNP) ("Juniper" or the "Company"), a women's health ther... Biopharmaceuticals, Urology, Drug Delivery, FDAJuniper Pharmaceuticals, oxybutynin, intra-vaginal, overactive bladder

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2040950

Source: HSMN NewsFeed - March 21, 2016 Category: Pharmaceuticals Source Type: news